{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"bf0e21e8a636a70a710a7d01ffe556a0ff2f269e247ecc9d1434b181cc79893e","attributes":{"feedName":"fda","feedSource":"fda","title":"Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling","description":"Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level.","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/alvogen-inc-issues-voluntary-nationwide-recall-fentanyl-transdermal-system-due-product-mislabeling","publicationDate":"2019-04-28T23:09:18.000Z","state":"sent","affected":[],"allergens":[],"audience":["consumers","professionals"],"categories":["drugs"],"contaminants":[],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"probable","token":"5d9e68c88b079e002a251a60"}}}